UiPath Inc. stocks have been trading down by -7.24 percent amid bearish sentiment over automation demand and growth sustainability.
Click Here for a Millionaire's POV on Trading PATH
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
Key Takeaways For PATH Traders
- Shares of PATH dropped roughly 16%–17% after its latest quarterly earnings, signaling heavy disappointment from the market.
- BofA raised its PATH price target from $13 to $15 but kept an Underperform rating, calling fiscal Q2 results mixed and AI-driven ARR growth uncertain.
- Insider action is in focus after CEO Daniel Dines sold about 1.4 million PATH shares for roughly $22.5M, while still controlling around 26.5 million Class A shares.
- Recent selling pressure has pushed PATH from the high $18s into the low teens, putting key support and sentiment levels to the test for short-term trading.
Live Update At 12:33:45 EDT: On Tuesday, September 08, 2026 UiPath Inc. stock [NYSE: PATH] is trending down by -7.24%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
PATH is trading like a classic momentum break. The daily chart shows UiPath Inc. rolling over from a recent high near $18.80 down to a close around $14.09 on 2026/09/08. That’s a steep slide in just a few sessions, and it followed earnings that clearly did not impress the Street.
Before the selloff, PATH had been grinding higher from the mid‑$15s into the high‑$18s. That uptrend is now cracked. The last two sessions show wide intraday ranges and heavy downside follow‑through, which tells traders that big funds are likely unloading, not just scalpers taking quick profits.
More Breaking News
- Ford Stock Slips As Sales, Recalls And Trade Risks Mount
- BTBT Stock Firms Up As Cloud Contracts Outshine Mining Past
- GRI Bio Surges As Phase 2a IPF Drug Data Nears
- TE Stock Jumps As Giga Arctic Data Center Plans Advance
Fundamentally, PATH still looks like a solid software platform with strong gross margins near 83% and annual revenue of about $1.61B. Profitability is improving: the latest quarterly report shows total revenue of $418.4M and net income of $22.5M, plus positive free cash flow of about $129.2M. The balance sheet is clean with very low debt and over $633M in cash. But at a price‑to‑sales ratio around 4.7 and a P/E near 25, traders are now asking whether PATH’s growth and AI story deserve that kind of premium when the chart is breaking down.
Why Traders Are Watching PATH After The Earnings Hit
PATH is front and center on many traders’ screens because the stock just experienced a textbook post‑earnings flush. UiPath Inc. dropped about 16%–17% after releasing its latest quarterly numbers, with one report noting an 11% hit early in the session and others confirming a deeper intraday slide. That kind of gap‑down and trend‑down combo usually means expectations were far ahead of reality.
The story behind the move matters. BofA looked at the same fiscal Q2 results and called them “mixed,” raising its PATH price target from $13 to $15 while still slapping on an Underperform rating. That’s a very specific message to the market: yes, the downside might be a bit less than before, but the firm still does not believe PATH deserves a bullish label. The bank also highlighted a key concern for traders — the question of whether AI tools will actually accelerate annual recurring revenue in a meaningful way, beyond modest margin gains.
For active trading, that uncertainty is fuel. When a hot AI‑linked name like PATH gets its growth story questioned by a major bank right after earnings, you often see a multi‑day repricing. Meanwhile, insider activity adds another layer: CEO Daniel Dines selling about 1.4 million shares for roughly $22.5M is a clear headline. Even though he still holds around 26.5 million Class A shares, short‑term traders read any large insider sale as a potential signal to tighten risk. Combine a big earnings miss reaction, cautious Wall Street commentary, and notable insider selling, and PATH becomes a prime battlefield for momentum and mean‑reversion strategies.
Conclusion
For traders, PATH is now a live case study in how story stocks reprice when reality fails to keep pace with the hype. UiPath Inc. still has strong gross margins, positive earnings, and a cash‑rich balance sheet, but the market just sent a loud message: that alone is not enough when growth and AI acceleration are in doubt. The slide from near $18.80 to close around $14 after earnings shows that expectations were stretched.
On the tape, PATH is trading heavy. Intraday 5‑minute candles around 2026/09/08 show multiple failed bounces near $14.20–$14.25 and a steady drift toward $14. That pattern tells short‑term traders that every pop is getting sold. Until PATH can hold a higher low and reclaim prior support levels, the path of least resistance stays down.
At the same time, this is exactly the kind of volatility that active trading thrives on. Sharp gaps, clean levels, and big volume give clear risk‑reward setups for both longs and shorts, as long as traders stay disciplined. That discipline includes not getting sucked into emotional entries on a fast-moving name like PATH; as Tim Bohen, lead trainer with StocksToTrade says, “I never chase price. The best opportunities allow me to enter on my terms, not when I’m feeling pressured.” As Tim Sykes likes to remind students, “Volatility is your best friend and your worst enemy — it will make you rich if you respect it, and blow you up if you don’t.” For PATH, the next few sessions will show whether this is just an overreaction flush or the start of a longer downtrend. Either way, it’s a name every serious trader should be tracking — for education, research, and well‑planned trades, not blind hope.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

